Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Japanese launch for imidafenacin for overactive bladder

June 12, 2007

Modulation of purinergic P2X and P2X2/3 receptors, a new strategy for treating urinary incontinence

June 8, 2007

Clinical trials in urological diseases

May 31, 2007

New therapeutic agents for renal-urological disorders disclosed in recent patents

May 23, 2007

Ortho Biotech Products to return BMP-7 program to Curis

May 22, 2007

New data on NX-1207 show sustained symptomatic improvement in BPH

May 10, 2007

Spectrum cleared to add Canadian sites to BPH program for ozarelix

May 8, 2007

Target enrollment reached in phase IIb study of ozarelix for BPH

May 4, 2007

New therapeutic agents for benign prostatic hyperplasia disclosed in recent Ranbaxy patent

May 4, 2007

Vardenafil begins phase II study in patients with BPH / News in Context

May 3, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...